61 results
Page 2 of 4
8-K
EX-99.1
5tsndsju
12 May 23
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter
5:20pm
8-K
EX-99.1
ye30makscdoc6wve
5 May 23
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
u4myka5dr 89e1
11 Oct 22
GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
6:07am
8-K
EX-99.1
c6gtrl7d08nf6k 4bm4
31 Aug 22
Results of Operations and Financial Condition
4:15pm
8-K
EX-99.1
1mxc boot45s6
16 Jun 22
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of
5:46pm
DEF 14A
gbwnq2vd9zpvj5spf
5 May 22
Definitive proxy
9:58pm
PRE 14A
blnx6zwod
26 Apr 22
Preliminary proxy
4:30pm
8-K
EX-99.1
ail0wpgyccgohuj
17 Nov 21
GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
4:05pm
8-K
EX-99.1
yfxltml272kphfqabcp
3 Nov 21
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
5:01pm
8-K
j71goific evrkns7
3 Nov 21
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
5:01pm
8-K
EX-99.1
1wv 8vshqg
14 Oct 21
GBS Inc. Announces its Pre-Submission package is with the FDA
12:00pm
10-K
kndgs ib1ry
16 Sep 21
Annual report
12:00am
8-K
EX-99.1
d6y1i qdy1nphxmqenl
11 Aug 21
GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
4:00pm